VOLUME 64 2003 NUMBER 6
Issue to be mailed the week of June
23, 2003
CME Pretest 625
CME Posttest 738
Brainstorms
626 The Ups and Downs of Novel Antiemetic Drugs, Part 2: An
Illustration. Stephen M. Stahl
[PDF]
Original Articles
628 Risperidone in the Treatment of Schizotypal Personality
Disorder. Harold W. Koenigsberg, Diedre Reynolds, Marianne
Goodman, Antonia S. New, Vivian Mitropoulou, Robert L. Trestman,
Jeremy Silverman, and Larry J. Siever
[Abstract]
[PDF]
635 Ethnic Differences in Use of Antipsychotic Medication
Among Texas Medicaid Clients With Schizophrenia. Jayme L.
Opolka, Karen L. Rascati, Carolyn M. Brown, Jamie C. Barner,
Michael T. Johnsrud, and P. Joseph Gibson
[Abstract]
[PDF]
640 A Double-Blind, Placebo-Controlled Study of the Efficacy
and Safety of Controlled-Release Fluvoxamine in Patients With
Obsessive-Compulsive Disorder. Eric Hollander, Lorrin M.
Koran, Wayne K. Goodman, John H. Greist, Philip T. Ninan, Haichen
Yang, David Li, and Luigi M. Barbato
[Abstract]
[PDF]
648 Morning Light Treatment Hastens the Antidepressant Effect
of Citalopram: A Placebo-Controlled Trial. Francesco
Benedetti, Cristina Colombo, Adriana Pontiggia, Alessandro
Bernasconi, Marcello Florita, and Enrico Smeraldi
[Abstract]
[PDF]
654 Sertraline Versus Imipramine Treatment of Comorbid Panic
Disorder and Major Depressive Disorder. Ulla Lepola, Mihaly
Arato, Young Zhu, and Carol Austin
[Abstract]
[PDF]
663 Chlorpromazine Equivalent Doses for the Newer Atypical
Antipsychotics. Scott W. Woods
[Abstract]
[PDF]
668 Conventional Antipsychotic Prescription in Unipolar
Depression, II: Withdrawing Conventional Antipsychotics in
Unipolar, Nonpsychotic Patients. [CME]
Ann M. Mortimer, Maria Martin, Jason A. Wheeler Vega, and Philip
J. Tyson
[Abstract]
[PDF]
673 Conventional, Atypical, and Combination Antipsychotic
Prescriptions: A 2-Year Comparison. Raymond P. Tempier and
Nicole H. Pawliuk
[Abstract]
[PDF]
680 Morbidity in 258 Bipolar Outpatients Followed for 1 Year
With Daily Prospective Ratings on the NIMH Life Chart Method. [CME] Robert M. Post, Kirk D.
Denicoff, Gabriele S. Leverich, Lori L. Altshuler, Mark A. Frye,
Trisha M. Suppes, A. John Rush, Paul E. Keck, Jr., Susan L.
McElroy, David A. Luckenbaugh, Chad Pollio, Ralph Kupka, and
Willem A. Nolen
[Abstract]
[PDF]
691 Enlargement of Brain Cerebrospinal Fluid Spaces as a
Predictor of Poor Clinical Outcome in Melancholia. Narcis
Cardoner, Jesus Pujol, Julio Vallejo, Mikel Urretavizcaya, Joan
Deus, Anna Lopez-Sala, Luisa Benlloch, and Jose M. Menchon
[Abstract]
[PDF]
698 "Outer-Directed Irritability": A Distinct Mood
Syndrome in Explosive Youth With a Disruptive Behavior Disorder?
Stephen J. Donovan, Edward V. Nunes, Jonathan W. Stewart, Don
Ross, Frederic M. Quitkin, Peter S. Jensen, and Donald F. Klein
[Abstract]
[PDF]
702 The Suicide Risk of Discharged Psychiatric Patients.
Ting-Pong Ho
[Abstract]
[PDF]
708 Psychiatric Symptoms in Patients With Chronic Hepatitis C
Receiving Interferon Alfa-2b Therapy. Michael R. Kraus, Arne
Schafer, Hermann Faller, Herbert Csef, and Michael Scheurlen
[Abstract]
[PDF]
715 An Open-Label Study of Citalopram in Body Dysmorphic
Disorder. Katharine A. Phillips and Fedra Najjar
[Abstract]
[PDF]
721 High-Dose Sildenafil Citrate for Selective Serotonin
Reuptake Inhibitor-Associated Ejaculatory Delay: Open Clinical
Trial. Stuart N. Seidman, Vanessa C. Pesce, and Steven P.
Roose
[Abstract]
[PDF]
726 A Double-Blind Comparison of Olanzapine Versus Risperidone
in the Acute Treatment of Dementia-Related Behavioral
Disturbances in Extended Care Facilities. Catherine S.
Fontaine, Linda S. Hynan, Kathleen Koch, Kristin Martin-Cook,
Doris Svetlik, and Myron F. Weiner
[Abstract]
[PDF]
Letters To the Editor
731 Venlafaxine for Pathological Crying After Stroke.
Amanda G. Smith, Mercedes Montealegre-Orjuela, James E. Douglas,
and Elizabeth A. Jenkins
[PDF]
732 Reporting Changes in Scores on the Cohen-Mansfield
Agitation Inventory Subscales. John Snowdon
[PDF]
- Reply by Clive G. Ballard
733 Oral Magnesium Ion Shortens Prolonged QTc Interval.
Daniel M. Bachman
[PDF]
734 Improvement in Negative Symptoms of Schizophrenia With
Antibodies to Tumor Necrosis Factor-alpha and to
Interferon-gamma: A Case Report. Simon V. Skurkovich, Yu A.
Aleksandrovsky, Vladimir P. Chekhonin, Igor A. Ryabukhin,
Konstantin O. Chakhava, and Boris Skurkovich
[PDF]
Book Reviews 736
NOW @ Psychiatrist.com 740
Information for authors
see July 2002, pages 591-593 or our Web siteat www.psychiatrist.com/author.htm